0001161697-23-000221.txt : 20230403
0001161697-23-000221.hdr.sgml : 20230403
20230403204742
ACCESSION NUMBER: 0001161697-23-000221
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210512
FILED AS OF DATE: 20230403
DATE AS OF CHANGE: 20230403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KATZAROFF JAMES C
CENTRAL INDEX KEY: 0001286868
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55072
FILM NUMBER: 23794800
MAIL ADDRESS:
STREET 1: 719 JADWIN AVE.
CITY: RICHLAND
STATE: WA
ZIP: 99352
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GlobeStar Therapeutics Corp
CENTRAL INDEX KEY: 0001502152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273480481
STATE OF INCORPORATION: WY
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 719 JADWIN AVENUE
CITY: RICHLAND
STATE: WA
ZIP: 99352
BUSINESS PHONE: 509-531-1671
MAIL ADDRESS:
STREET 1: 719 JADWIN AVENUE
CITY: RICHLAND
STATE: WA
ZIP: 99352
FORMER COMPANY:
FORMER CONFORMED NAME: AngioSoma, Inc.
DATE OF NAME CHANGE: 20160622
FORMER COMPANY:
FORMER CONFORMED NAME: First Titan Corp.
DATE OF NAME CHANGE: 20100927
4
1
form_4.xml
FORM 4 FOR 05-12-2021
X0407
4
2021-05-12
0
0001502152
GlobeStar Therapeutics Corp
GSTC
0001286868
KATZAROFF JAMES C
719 JADWIN AVE.
RICHLAND
WA
99352
1
1
0
0
CEO
0
Common stock
2023-04-03
2023-04-03
4
J
0
70422535
.0071
A
80422535
D
Options
.03
2021-05-12
4
A
0
30000000
0
A
2021-05-12
2023-05-12
Common stock
30000000
30000000
D
Options
.009
2023-02-24
4
A
0
35000000
0
A
2023-08-24
2028-02-24
Common stock
35000000
65000000
D
Shares acquired pursuant to conversion of debt of $50,000.
Options vest 50% when granted and balance ratably on a daily basis during the 24 month period commencing on date of grant.
Vested Options are exercisable 6 months after date of grant and thereafter until 5 years after the date of grant.
James C. Katzaroff
2023-04-03